The FDA has approved a new, voice guided epinephrine auto-injector for emergency use to counter the effects of anaphylaxis.
Sanofi announced approval for the Auvi-Q device in a press release from their Paris headquarters on August 13, 2012. The device is roughly credit card size and fits easily in a pocket or purse. Activating the device by pulling off the cap initiates a voice recording that steps the user through the procedure.
Here is a video provided by Sanofi demonstrating the Auvi-Q’s use:
The step-by-step voice prompts make this device ideal for use by care-givers, teachers, school nurses and babysitters.